An intravenous programmed death-1 inhibitor to treat advanced melanoma that has progressed following therapy with Yervoy (ipilimumab).
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An intravenous programmed death-1 inhibitor to treat advanced melanoma that has progressed following therapy with Yervoy (ipilimumab).
If you have a Hayes login, click here to view the full report on the Knowledge Center.